nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—Pruritus—Teniposide—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Varenicline—Arrhythmia—Carmustine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Varenicline—Cardiac disorder—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Varenicline—Body temperature increased—Fludarabine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Varenicline—Mental disorder—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Varenicline—Erythema—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Varenicline—Malnutrition—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Varenicline—Cough—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Varenicline—Angiopathy—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Varenicline—Diarrhoea—Teniposide—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Varenicline—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Varenicline—Myalgia—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Varenicline—Chest pain—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Varenicline—Back pain—Carmustine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Varenicline—Discomfort—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Varenicline—Mental disorder—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Varenicline—Chills—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Varenicline—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Varenicline—Urine output increased—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Varenicline—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Varenicline—Vision blurred—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Varenicline—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Varenicline—Tremor—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Varenicline—Oedema—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Varenicline—Erythema—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Varenicline—Infection—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Varenicline—Anaemia—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Varenicline—Back pain—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Varenicline—Vomiting—Teniposide—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Varenicline—Agitation—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Varenicline—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Varenicline—Asthenia—Fludarabine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Varenicline—Rash—Teniposide—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Varenicline—Dermatitis—Teniposide—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Varenicline—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Varenicline—Headache—Teniposide—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Varenicline—Pruritus—Fludarabine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Varenicline—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Varenicline—Back pain—Mitoxantrone—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Varenicline—Anorexia—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Varenicline—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Varenicline—Anaemia—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Varenicline—Agitation—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Varenicline—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Varenicline—Polyuria—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Varenicline—Hypotension—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Varenicline—Diarrhoea—Fludarabine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Varenicline—Convulsion—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Hypertension—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Nausea—Teniposide—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Anaemia—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Vertigo—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Chest pain—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Myalgia—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Anxiety—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Varenicline—Malaise—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Varenicline—Dyspnoea—Bleomycin—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Varenicline—Renal failure acute—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Varenicline—Convulsion—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Varenicline—Hypertension—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Varenicline—Oedema—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Varenicline—Decreased appetite—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Varenicline—Myalgia—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Varenicline—Visual disturbance—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Cough—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Infection—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Vomiting—Fludarabine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Convulsion—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Rash—Fludarabine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Dermatitis—Fludarabine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Hypertension—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Pain—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Varenicline—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Varenicline—Headache—Fludarabine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Varenicline—Tachycardia—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Varenicline—Myalgia—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Chest pain—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Anxiety—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Lethargy—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Varenicline—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Varenicline—Discomfort—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Varenicline—Oedema—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Varenicline—Anorexia—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Varenicline—Infection—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Nervous system disorder—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Varenicline—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Hypotension—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Oedema—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Nausea—Fludarabine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Infection—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Shock—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Urticaria—Bleomycin—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Anorexia—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Body temperature increased—Bleomycin—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Insomnia—Carmustine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Irritability—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Varenicline—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Varenicline—Mood swings—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Hypotension—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Dyspnoea—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Somnolence—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Anorexia—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Varenicline—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Decreased appetite—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Hypotension—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Varenicline—Insomnia—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Varenicline—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Varenicline—Constipation—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Pain—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Breast disorder—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Varenicline—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Varenicline—Decreased appetite—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Varenicline—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Somnolence—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Feeling abnormal—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Fatigue—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Asthenia—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Pain—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Constipation—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Asthma—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Varenicline—Pruritus—Bleomycin—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Varenicline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Fatigue—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Varenicline—Constipation—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Pain—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Abdominal pain—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Body temperature increased—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Body temperature increased—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Varenicline—Abdominal pain—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Varenicline—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Varenicline—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Urticaria—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Hypersensitivity—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Vomiting—Bleomycin—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Infestation NOS—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Infestation—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Depression—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Rash—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Dermatitis—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Asthenia—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Stomatitis—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Hypersensitivity—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Epistaxis—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Asthenia—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Diarrhoea—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Nausea—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Asthenia—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Varenicline—Dizziness—Carmustine—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Varenicline—Diarrhoea—Vincristine—lymphatic system cancer	0.000981	0.000981	CcSEcCtD
Varenicline—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000967	0.000967	CcSEcCtD
Varenicline—Urethral disorder—Methotrexate—lymphatic system cancer	0.00096	0.00096	CcSEcCtD
Varenicline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Varenicline—Vomiting—Carmustine—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Varenicline—Dizziness—Vincristine—lymphatic system cancer	0.000948	0.000948	CcSEcCtD
Varenicline—Rash—Carmustine—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Varenicline—Dermatitis—Carmustine—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Varenicline—Visual impairment—Methotrexate—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Varenicline—Headache—Carmustine—lymphatic system cancer	0.000941	0.000941	CcSEcCtD
Varenicline—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000926	0.000926	CcSEcCtD
Varenicline—Eye disorder—Methotrexate—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Varenicline—Tinnitus—Methotrexate—lymphatic system cancer	0.000913	0.000913	CcSEcCtD
Varenicline—Vomiting—Vincristine—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Varenicline—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000909	0.000909	CcSEcCtD
Varenicline—Rash—Vincristine—lymphatic system cancer	0.000904	0.000904	CcSEcCtD
Varenicline—Dermatitis—Vincristine—lymphatic system cancer	0.000903	0.000903	CcSEcCtD
Varenicline—Headache—Vincristine—lymphatic system cancer	0.000898	0.000898	CcSEcCtD
Varenicline—Nausea—Carmustine—lymphatic system cancer	0.000892	0.000892	CcSEcCtD
Varenicline—Angiopathy—Methotrexate—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Varenicline—Vomiting—Mitoxantrone—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Varenicline—Immune system disorder—Methotrexate—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Varenicline—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Varenicline—Rash—Mitoxantrone—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Varenicline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Varenicline—Chills—Methotrexate—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Varenicline—Headache—Mitoxantrone—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Varenicline—Mental disorder—Methotrexate—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Varenicline—Erythema—Methotrexate—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Varenicline—Malnutrition—Methotrexate—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Varenicline—Nausea—Vincristine—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Varenicline—Dysgeusia—Methotrexate—lymphatic system cancer	0.000835	0.000835	CcSEcCtD
Varenicline—Nausea—Mitoxantrone—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
Varenicline—Back pain—Methotrexate—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Varenicline—Vision blurred—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Varenicline—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Varenicline—Anaemia—Methotrexate—lymphatic system cancer	0.000788	0.000788	CcSEcCtD
Varenicline—Malaise—Methotrexate—lymphatic system cancer	0.000769	0.000769	CcSEcCtD
Varenicline—Vertigo—Methotrexate—lymphatic system cancer	0.000766	0.000766	CcSEcCtD
Varenicline—Cough—Methotrexate—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Varenicline—Convulsion—Methotrexate—lymphatic system cancer	0.000738	0.000738	CcSEcCtD
Varenicline—Myalgia—Methotrexate—lymphatic system cancer	0.000726	0.000726	CcSEcCtD
Varenicline—Chest pain—Methotrexate—lymphatic system cancer	0.000726	0.000726	CcSEcCtD
Varenicline—Arthralgia—Methotrexate—lymphatic system cancer	0.000726	0.000726	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000721	0.000721	CcSEcCtD
Varenicline—Discomfort—Methotrexate—lymphatic system cancer	0.000717	0.000717	CcSEcCtD
Varenicline—Infection—Methotrexate—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Varenicline—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000682	0.000682	CcSEcCtD
Varenicline—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Varenicline—Skin disorder—Methotrexate—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Varenicline—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000672	0.000672	CcSEcCtD
Varenicline—Anorexia—Methotrexate—lymphatic system cancer	0.000663	0.000663	CcSEcCtD
Varenicline—Hypotension—Methotrexate—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000634	0.000634	CcSEcCtD
Varenicline—Insomnia—Methotrexate—lymphatic system cancer	0.000629	0.000629	CcSEcCtD
Varenicline—Dyspnoea—Methotrexate—lymphatic system cancer	0.00062	0.00062	CcSEcCtD
Varenicline—Somnolence—Methotrexate—lymphatic system cancer	0.000618	0.000618	CcSEcCtD
Varenicline—Dyspepsia—Methotrexate—lymphatic system cancer	0.000612	0.000612	CcSEcCtD
Varenicline—Decreased appetite—Methotrexate—lymphatic system cancer	0.000605	0.000605	CcSEcCtD
Varenicline—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000601	0.000601	CcSEcCtD
Varenicline—Fatigue—Methotrexate—lymphatic system cancer	0.0006	0.0006	CcSEcCtD
Varenicline—Pain—Methotrexate—lymphatic system cancer	0.000595	0.000595	CcSEcCtD
Varenicline—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000573	0.000573	CcSEcCtD
Varenicline—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000569	0.000569	CcSEcCtD
Varenicline—Urticaria—Methotrexate—lymphatic system cancer	0.000553	0.000553	CcSEcCtD
Varenicline—Abdominal pain—Methotrexate—lymphatic system cancer	0.00055	0.00055	CcSEcCtD
Varenicline—Body temperature increased—Methotrexate—lymphatic system cancer	0.00055	0.00055	CcSEcCtD
Varenicline—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000513	0.000513	CcSEcCtD
Varenicline—Asthenia—Methotrexate—lymphatic system cancer	0.000499	0.000499	CcSEcCtD
Varenicline—Pruritus—Methotrexate—lymphatic system cancer	0.000492	0.000492	CcSEcCtD
Varenicline—Diarrhoea—Methotrexate—lymphatic system cancer	0.000476	0.000476	CcSEcCtD
Varenicline—Dizziness—Methotrexate—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Varenicline—Vomiting—Methotrexate—lymphatic system cancer	0.000442	0.000442	CcSEcCtD
Varenicline—Rash—Methotrexate—lymphatic system cancer	0.000439	0.000439	CcSEcCtD
Varenicline—Dermatitis—Methotrexate—lymphatic system cancer	0.000438	0.000438	CcSEcCtD
Varenicline—Headache—Methotrexate—lymphatic system cancer	0.000436	0.000436	CcSEcCtD
Varenicline—Nausea—Methotrexate—lymphatic system cancer	0.000413	0.000413	CcSEcCtD
